Alzheimer's-related Resource Centers for Minority Aging Research (AD/ADRD RCMAR) (P30 Clinical Trial Optional) | RFA AG 23 025

Opportunity Information: Apply for RFA AG 23 025

The Alzheimer’s-related Resource Centers for Minority Aging Research (AD/ADRD RCMAR) funding opportunity (RFA-AG-23-025) is an NIH center grant (P30; clinical trial optional) that supports institutions seeking to establish or renew a Resource Center for Minority Aging Research focused on behavioral and social science aspects of Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD). The program is designed to build long-term institutional capacity by creating a hub that combines research infrastructure with structured mentorship, with a strong emphasis on collaboration and an environment that actively strengthens diversity, equity, inclusion, and accessibility (DEIA).

The program has two main goals. First, it aims to diversify the AD/ADRD research workforce by mentoring promising scientists from diverse backgrounds who are working in priority areas of social, behavioral, psychological, and economic research related to AD/ADRD. Second, it seeks to develop and sustain the research and mentoring infrastructure needed to produce rigorous, high-impact behavioral and social science research that can drive scientific advances in AD/ADRD. In practice, applicants are expected to propose a multipronged approach that does more than fund isolated projects; the center should function as a coordinated platform that develops investigators, supports research development, and accelerates progress in the targeted priority areas.

In terms of scientific scope, the FOA highlights a range of behavioral and social science domains tied to AD/ADRD. Priority topics include cognitive and dementia epidemiology, behavioral and social pathways that influence AD/ADRD risk and progression, early psychological and functional changes that may signal emerging impairment, prevention-oriented research, dementia care and care delivery, caregiving and care partners, and research addressing health disparities and health inequities in AD/ADRD. The intent is to support work that meaningfully advances understanding of how social conditions, behaviors, psychological factors, and structural inequities shape risk, detection, outcomes, and lived experience for people affected by dementia, particularly in populations that have been historically underrepresented in research and disproportionately burdened by disease.

The eligible applicant pool is broad and includes many types of U.S.-based organizations and governments, such as public and private institutions of higher education, nonprofits (with or without 501(c)(3) status), for-profit organizations (other than small businesses) and small businesses, and multiple levels of government (state, county, city/township, special districts), as well as independent school districts and public housing authorities/Indian housing authorities. The FOA also explicitly calls out additional eligible applicants that align with the program’s workforce and equity aims, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), along with faith-based or community-based organizations, regional organizations, and certain tribal governments and tribal organizations.

Foreign eligibility is limited. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply as the primary applicant organization, and non-domestic components of U.S. organizations are also not eligible to apply. However, foreign components are allowed under NIH policy (as defined in the NIH Grants Policy Statement), meaning an otherwise eligible U.S. applicant may include certain foreign elements when justified and compliant with NIH rules.

Administratively, this is a discretionary grant opportunity in the health category (CFDA/Assistance Listing 93.866) administered by the National Institutes of Health. The opportunity’s original closing date was October 21, 2022, and the listed award ceiling is $500,000. Overall, the FOA is geared toward supporting centers that can both cultivate a more diverse pipeline of AD/ADRD behavioral and social science researchers and build the shared infrastructure and mentoring systems needed to produce durable, rigorous research contributions, particularly in areas that address prevention, care, caregiving, and persistent inequities in dementia outcomes.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Alzheimer's-related Resource Centers for Minority Aging Research (AD/ADRD RCMAR) (P30 Clinical Trial Optional)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
• This funding opportunity was created on 2022-08-05.
• Applicants must submit their applications by 2022-10-21. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $500,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA AG 23 025

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: